Recall of BEHRING ELISA PROCESSOR SYSTEM - VARICELLA IGM ENZYGNOST

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    25156
  • Event Risk Class
    II
  • Event Initiated Date
    2015-10-08
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Siemens healthcare diagnostics products has confirmed that the mentioned enzygnost anti-vzv/igg lots can show a higher variation in homogeneity. this can lead to invalid runs by not meeting the run validation criterion for the reference p/n at the start and end of a series.

Device

  • Model / Serial
    Model Catalog: OWLT15 (Lot serial: 45077); Model Catalog: OWLT15 (Lot serial: 44218); Model Catalog: OWLT15 (Lot serial: 44309); Model Catalog: OWLT15 (Lot serial: 44565)
  • Product Description
    BEHRING ELISA PROCESSOR SYSTEM- VARICELLA IGG ENZYGNOST
  • Manufacturer

Manufacturer

  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
  • Source
    HC